Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study).

Perez-Molina JA, Rubio R, Rivero A, Pasquau J, Suárez-Lozano I, Riera M, Estébanez M, Palacios R, Sanz-Moreno J, Troya J, Mariño A, Antela A, Navarro J, Esteban H, Moreno S; GeSIDA 7011 Study Group.

J Antimicrob Chemother. 2017 Jan;72(1):246-253. Epub 2016 Sep 13.

PMID:
27629070
2.

[Adherence to entecavir for chronic hepatitis B and correlation with effectiveness].

Romero Díaz-Maroto V, Sánchez Cuervo M, Rodríguez Sagrado MÁ, Bermejo Vicedo T.

Farm Hosp. 2015 Nov 1;39(6):378-81. doi: 10.7399/fh.2015.39.6.8374. Spanish.

3.

The influence of patient beliefs and treatment satisfaction on the discontinuation of current first-line antiretroviral regimens.

Casado JL, Marín A, Romero V, Bañón S, Moreno A, Perez-Elías MJ, Moreno S, Rodriguez-Sagrado MA.

HIV Med. 2016 Jan;17(1):46-55. doi: 10.1111/hiv.12280. Epub 2015 Jul 6.

PMID:
26149493
4.

Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial.

Perez-Molina JA, Rubio R, Rivero A, Pasquau J, Suárez-Lozano I, Riera M, Estébanez M, Santos J, Sanz-Moreno J, Troya J, Mariño A, Antela A, Navarro J, Esteban H, Moreno S; GESIDA 7011 Study Group.

Lancet Infect Dis. 2015 Jul;15(7):775-84. doi: 10.1016/S1473-3099(15)00097-3. Epub 2015 Jun 7. Erratum in: Lancet Infect Dis. 2015 Sep;15(9):998.

PMID:
26062881
5.

Missing scheduled visits in the outpatient clinic as a marker of short-term admissions and death.

Colubi MM, Pérez-Elías MJ, Elías L, Pumares M, Muriel A, Zamora AM, Casado JL, Dronda F, López D, Moreno S; SEAD Study Group.

HIV Clin Trials. 2012 Sep-Oct;13(5):289-95. doi: 10.1310/hct1305-289.

PMID:
23134630
6.

Safe coadministration of raltegravir-based HAART in HIV-infected patients with HCV-cirrhosis receiving triple therapy with telaprevir or boceprevir.

Moreno A, Quereda C, Montes M, Pérez-Elías MJ, Casado JL, Rodríguez-Sagrado MA, Mateos ML, Dronda F, Bárcena R, Del Campo S, Moreno S.

J Acquir Immune Defic Syndr. 2012 Nov 1;61(3):e47-9. doi: 10.1097/QAI.0b013e31826cc275. No abstract available.

PMID:
23095936
7.

[Treatment adherence and persistence in patients with chronic hepatitis B virus infection].

Martín-Mateos RM, Moreira-Vicente VF, Cuesta-López I, Rodríguez-Sagrado MA, Garcia-Alonso FJ, González-Tallón AI, Bárcena-Marugán R, Milicua-Salamero JM.

Gastroenterol Hepatol. 2012 Apr;35(4):293-4. doi: 10.1016/j.gastrohep.2011.12.011. Epub 2012 Feb 28. Spanish. No abstract available.

PMID:
22377472
8.

[Failure modes and effects analysis in the prescription, validation and dispensing process].

Delgado Silveira E, Alvarez Díaz A, Pérez Menéndez-Conde C, Serna Pérez J, Rodríguez Sagrado MA, Bermejo Vicedo T.

Farm Hosp. 2012 Jan-Feb;36(1):24-32. doi: 10.1016/j.farma.2010.12.002. Epub 2011 Apr 22. Spanish.

PMID:
21514867
9.

Safe co-administration of raltegravir, pegylated-interferon and, ribavirin in HIV individuals with hepatitis C virus-related liver damage.

Moreno A, Quereda C, Fortún J, Bárcena R, Pérez-Elías MJ, Casado JL, Rodríguez-Sagrado MA, Mateos ML, Blesa C, Moreno S.

AIDS. 2010 May 15;24(8):1231-3. doi: 10.1097/QAD.0b013e328336e9b3. No abstract available.

PMID:
20421744
10.

Partial splenic embolization and peg-IFN plus RBV in liver transplanted patients with hepatitis C recurrence: safety, efficacy and long-term outcome.

Bárcena R, Moreno A, Foruny JR, Blázquez J, Graus J, Riesco JM, Blesa C, García-Hoz F, Sánchez J, Gil-Grande L, Nuño J, Fortún J, Rodriguez-Sagrado MA, Moreno A.

Clin Transplant. 2010 May-Jun;24(3):366-74. doi: 10.1111/j.1399-0012.2009.01081.x. Epub 2009 Oct 22.

PMID:
19863593
11.

Effect of treatment with efavirenz on neuropsychiatric adverse events of interferon in HIV/HCV-coinfected patients.

Quereda C, Corral I, Moreno A, Pérez-Elías MJ, Casado JL, Dronda F, Rodríguez-Sagrado MA, Hernández B, Moreno S.

J Acquir Immune Defic Syndr. 2008 Sep 1;49(1):61-3. doi: 10.1097/QAI.0b013e31817bbeb9.

PMID:
18667933
12.

Safe use of pegylated interferon/ribavirin in hepatitis C virus cirrhotic patients with hypersplenism after partial splenic embolization.

Foruny JR, Blázquez J, Moreno A, Bárcena R, Gil-Grande L, Quereda C, Pérez-Elías MJ, Moreno J, Sánchez J, Muriel A, Rodriguez-Sagrado MA, Moreno S.

Eur J Gastroenterol Hepatol. 2005 Nov;17(11):1157-64.

PMID:
16215426

Supplemental Content

Loading ...
Support Center